Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-19 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.44 | 3e-18 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-18 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-15 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-14 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-12 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-11 |